The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Gladstone investigators identify a new protective action for the powerful anti-HIV factor, APOBEC3G

Scientists at the Gladstone Institute of Virology and Immunology (GIVI) have identified a previously unknown function of APOBEC3G (A3G), a protein that acts against HIV, a finding that may lead to new approaches for controlling HIV infection.

The work is published today, Oct. 2, 2006, in Proceedings of the National Academy of Sciences, USA.

The research, conducted by scientists in the laboratory of GIVI Director Warner C. Greene, MD, PhD, explains why CD4 T cells the immune system cells targeted by HIV -- are sometimes so susceptible to HIV infection and at other times are highly resistant.

Scientists have known that resistant CD4 T cells, called "resting cells," are made up predominantly of CD4+ T cells that are in an inactive state, awaiting a stimulus to move into action. In these cells, A3G blocks HIV at an early step in its life cycle. However, when resting CD4 T cells are stimulated by a foreign protein or other signal, A3G is rapidly recruited into large RNA protein complexes within the cells. This change neutralizes the anti-HIV properties of A3G, opening the door to HIV infection.

In the current study, the researchers set out to decipher the protein and RNA components of the A3G RNA protein complexes. In so doing, Ya-Lin Chiu, PhD, a postdoctoral fellow in Greene's laboratory, determined that the complexes help to prevent a threat within cells posed by a class of "jumping genes," or retro-elements, which are sequences of DNA that change position within the genome, causing mutations, activating or inactivating other genes, or duplicating themselves, thereby increasing the quantity of DNA in each cell.

As with HIV, the replication and movement of these retro-elements to new chromosomal sites with potentially damaging effect involves copying DNA into RNA and then back into DNA again. The A3G RNA protein complex, Chiu determined, interrupts this retro-element replication cycle by binding the retro-element RNAs and sequester
'"/>

Contact: Valerie Tucker
vtucker@gladstone.ucsf.edu
415-734-2019
University of California - San Francisco
2-Oct-2006


Page: 1 2

Related medicine news :

1. Gladstone Institutes ranks #1 in The Scientist survey of Best Places for Postdocs to Work
2. Institute of Medicine elects Gladstone Director Warner Greene
3. Damon Runyon renews its $2.25 million investment to support young clinical cancer investigators
4. The Burroughs Wellcome Fund awards $8 million to infectious disease investigators
5. Telebriefing: NIH announces program for new scientific investigators
6. MUHC investigators search for the root of sexual pain in women
7. BIDMC investigators receive award to study pathways responsible for obesity, type 2 diabetes
8. Nepalese researchers identify cost-effective treatment for drug-resistant typhoid
9. STAMP system can help professionals to identify potentially violent individuals
10. Diabetes professionals join forces to identify gaps in diabetes care and better self care
11. OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy

Post Your Comments:
(Date:11/25/2009)... New minimally-invasive pro...inus pain and decrease the risk of sinusitis, or s...e physicians of the Atlanta Snoring Institute. Te...and congested sinuses without having to remove any... The advantages of these breakthroughs in treating...
(Date:11/25/2009)...,, VANCOUVER,Nov.25/PRNewswire/-- AdamDreamHeal...ealingintentionschangesthephysiologyofsomeoneatadi...atatimeunknowntoavolunteerwhowasmonitoredbyaquanti...AandCanada. ,, OnNovember8inVancouver,B.C.Adami...ent.Tofocusintentions,Adamcreatedavideoclipofaspec...
(Date:11/24/2009)... Eating high amounts of salt is linked to a signi... disease, states a paper published today in the B...ied out jointly by the World Health Organization,s...University of Warwick and University Hospital in C...ion Excellence Centre in Hypertension based at the...
(Date:11/24/2009)...(Boston) Researchers from Boston University Schoo...medical Engineering Department have identified a n...distinguish between cancer and normal cells with a...earchers have developed a new computational strate...key biological pathways (molecular circuits) that ...
(Date:11/24/2009)...,, DALLAS,Nov.24/PRNewswire-USNewswire/--TheBay...rofoneofthelargestcancerclinicaltrialscooperativeg...heNationalCancerInstitute,SouthwestOncologyGroupco...s,andtoimprovethequalityoflifeforcancersurvivors. ...eradditional,importantclinicaltrialstocancerpatien...
Breaking Medicine News(10 mins):Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 2Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 3Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 4Health News:Intriguing Scientific Results from World's Largest Intention Healing Project: DreamHealer 2Health News:High salt intake linked to strokes and cardiovascular disease 2Health News:Researchers identify proteins in lung cancer cells that may provide potential drug targets 2Health News:Baylor Sammons Cancer Center Joins One of Nation's Largest Cancer Clinical Trials Groups 2
(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/--AnadysPharmaceutica...entatthe21stAnnualPiperJaffrayHealthcareConference....TheconferenceisbeingheldatTheNewYorkPalaceHotel.S...rofAnadys,willprovideanoverviewofAnadysanditsclini...orporatepresentationwillbesimultaneouslywebcastand...
(Date:11/24/2009)...ON,Calif.,Nov.24/PRNewswire-FirstCall/--ThoratecCo...dmechanicalcirculatorysupporttherapiestosave,suppo...ticipatinginthe21stAnnualPiperJaffrayHealthCareCon...cutivevicepresidentandchieffinancialofficer,willpr...ernStandardTime(5:30a.m.,PacificStandardTime). ,...
(Date:11/24/2009)...N.C.,Nov.24/PRNewswire/--PharmaceuticalInstitute,a...epharmaceuticalandbiotechindustry,todayannouncedth...Thenew HospitalMarketplace e-courseisthenewestaddi...ries,acomprehensiveseriesofe-coursesdesignedtofill...owledgeforcommercialprofessionals. ,, Thenewthr...
Breaking Medicine Technology:Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 2 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 1 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 2 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 3 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 4 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 5 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 6 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 7 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 8 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 9Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease 3B Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver 4745 1Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease 3B Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver 4745 2Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 1Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 2Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 3Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 4
Other News:
...PITTSBURGH-- Carnegie Mellon University researcher... dependence on fossil fuels and curb costly transp...icates the time is right for America to begin a tr...d Scott Matthews, an assistant professor in the Ci...
...ANN ARBOR, Mich. -- For women diagnosed with a typ...st is not the only treatment option. Breast conser...ing the more common invasive cancer, can also be e...g to a new study from researchers at the Universit...
...Some ethnic groups may be more susceptible to adve....com today.......Adverse drug reactions (ADRs) are...al factors including genetic make up, age, sex, an...ity to ADRs. But it is not known to what extent su...
...The idea that 'puppy fat' in children disappears a... put the future health of children at risk, says a...from some ethnic minorities and lower socioeconomi..., putting them at even more danger of long-term he...
health news:Carnegie Mellon researchers say use of switchgrass could solve energy woes 2health news:Carnegie Mellon researchers say use of switchgrass could solve energy woes 3health news:Breast conservation a good option for non-invasive, 'early' breast cancer, U-M study shows 2
...al puzzle of how estrogen goes from protecting wom...ir risk later in life may have been found.... ...M...hanges in blood vessel chemistry that may explain ... occurs in older women, taking it from a dilator o...
... The history of hormone therapy drugs once though...vital and young shows why it is so important to c...benefits of drugs, say researchers from Wake Fores...mone therapy debate is one more example of a large...
...lished in this week's New England Journal of Medic...al refutes the popular belief that getting an epid...sarean delivery. ......In a study of 750 women, r... cervix is less than four centimeters dilated did ...
...A widely-used class of drugs that keep the HIV-vir...rious and potentially lethal heart rhythm disturba...c-led investigation appears in the current edition......In collaboration with colleagues from the HIV P...
health news:Changing chemistry helps explain estrogen threat to the heart 2health news:Changing chemistry helps explain estrogen threat to the heart 3health news:Hormone therapy controversy raises drug safety issues 2health news:Hormone therapy controversy raises drug safety issues 3health news:Study finds no reason for expectant mothers to shy away from early epidurals 2health news:HIV patients may be at risk of heart problems when taking protease inhibitor drugs 2health news:HIV patients may be at risk of heart problems when taking protease inhibitor drugs 3